Chr. Hansen announced the acquisition of the US-based nutritional physiology company to expand company’s microbial platform while increasing its footprint into livestock industry. The total price of the acquisition is USD 185 million funded through Chr. Hansen’s own cash holding and current credit facilities.

Company cited that the demands for natural solutions that advance health and productivity in the livestock industry is on the rise and the expected growth for microbial solutions in this industry is 7-9%.  At Chr. Hansen, the animal health and nutrition segment provides probiotics to many customers in the global livestock industry. Through the acquisition company is anticipated to expand microbial platform and expands its presence into the beef cattle segment.

About Nutritional Physiology

Founded in 1993 and headquartered USA, the company is supplier of probiotic products to beef cattle. Company’s Key products include Bovamine, Bovamine Defend, Bovamine Dairy, and PoultriMax designed to improve gut health, maximize the energy capture and aid the natural immune system in livestock and poultry. 

About The Chr. Hansen Group:

Founded in 1874, Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. At Chr. Hansen, the animal health and nutrition business supplies probiotics to various customers in the global livestock industry.  Company is one of the key supplier of probiotics to dietary supplements, infant formula and dairy, Company posted revenue of EUR 1,097 million for the financial year 2017/18.